LY3537982 Clinical Trials (2026): 8 Studies for Healthy & Carcinoma, Non-Small-Cell Lung

Where to Participate: All LY3537982 Trial Sites in the U.S. (88 sites across 37 states)

Every actively recruiting LY3537982trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

LY3537982 clinical trials at a glance: phase × recruitment status

Recruiting LY3537982 clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

LY3537982 clinical trials by indication

LY3537982 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All LY3537982 trials (8)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

LY3537982 clinical trials: frequently asked questions

How many LY3537982 clinical trials are there?

8 LY3537982 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 6 are marked completed.

Are LY3537982 clinical trials recruiting in 2026?

Yes — 1 LY3537982 trial is actively recruiting in 2026, with 88 U.S. sites across 37 states. See the recruiting trials and the per-state site list further down this page.

What conditions is LY3537982 being studied for?

LY3537982 is being studied for Healthy, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms, Neoplasm Metastasis and 5 more. The trials are grouped by indication on this page.

What phase is LY3537982 in?

LY3537982 clinical trials span 1 Phase 3, 6 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors LY3537982 clinical trials?

The lead sponsor across the most LY3537982 trials is Eli Lilly and Company. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming LY3537982as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.